ConjuChem Inc

CJB-T

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about CJB-T

Signal
Opinion
Expert
WAIT
WAIT
April 8, 2004
Coming-out with clinical trial results on Monday. Stock has had a huge run in anticipation of this. Good company, but wait for the results.
Show full opinionHide full opinion
ConjuChem Inc (CJB-T)
April 8, 2004
Coming-out with clinical trial results on Monday. Stock has had a huge run in anticipation of this. Good company, but wait for the results.
DON'T BUY
DON'T BUY
April 7, 2004
A very interesting company but has had a big run. Would look elsewhere.
Show full opinionHide full opinion
ConjuChem Inc (CJB-T)
April 7, 2004
A very interesting company but has had a big run. Would look elsewhere.
SELL
SELL
March 25, 2004
An incredibly expensive stock. Market has been expecting some trial news that they believe will cause drug companies to want to own the Company. Risky.
Show full opinionHide full opinion
ConjuChem Inc (CJB-T)
March 25, 2004
An incredibly expensive stock. Market has been expecting some trial news that they believe will cause drug companies to want to own the Company. Risky.
PAST TOP PICK
PAST TOP PICK
March 2, 2004
(A top pick on Dec 4/03. Up 156%.) Still likes of a lot. Will probably go into the index this month. A couple of analysts are calling it the next RIM. The market for their diabetes product is absolutely gigantic.
Show full opinionHide full opinion
ConjuChem Inc (CJB-T)
March 2, 2004
(A top pick on Dec 4/03. Up 156%.) Still likes of a lot. Will probably go into the index this month. A couple of analysts are calling it the next RIM. The market for their diabetes product is absolutely gigantic.
HOLD
HOLD
January 23, 2004
Has great technology. Had a huge run. They have a phase two trial going on for diabetes and if it works, the stock is $20. If not, could go back to $.50. Caution.
Show full opinionHide full opinion
ConjuChem Inc (CJB-T)
January 23, 2004
Has great technology. Had a huge run. They have a phase two trial going on for diabetes and if it works, the stock is $20. If not, could go back to $.50. Caution.
TOP PICK
TOP PICK
December 4, 2003
Product had a wide platform of multiple uses and a couple of products didn't work so stock dropped drastically. Now using it with a diabetes product, which is getting a lot of attention. A trading stock. Trade at $7/8 before the trial results come out
Show full opinionHide full opinion
ConjuChem Inc (CJB-T)
December 4, 2003
Product had a wide platform of multiple uses and a couple of products didn't work so stock dropped drastically. Now using it with a diabetes product, which is getting a lot of attention. A trading stock. Trade at $7/8 before the trial results come out
WEAK BUY
WEAK BUY
September 22, 2003
New issue gave them needed cash. In the process of digesting it. Now looking for some better results in the diabetes applications. Could be a joint venture down the road. Volatile area.
Show full opinionHide full opinion
ConjuChem Inc (CJB-T)
September 22, 2003
New issue gave them needed cash. In the process of digesting it. Now looking for some better results in the diabetes applications. Could be a joint venture down the road. Volatile area.
DON'T BUY
DON'T BUY
June 19, 2003
Up 317% on a year to date basis. Seems to be finding support around the $1.60 level. May be a little high now.
Show full opinionHide full opinion
ConjuChem Inc (CJB-T)
June 19, 2003
Up 317% on a year to date basis. Seems to be finding support around the $1.60 level. May be a little high now.
Showing 16 to 23 of 23 entries